Inventor · disambiguated record
Evripidis Gavathiotis
Also filed as: GAVATHIOTIS EVRIPIDIS
23 granted patents·19 pending applications·54 citations·filing 2008–2024
93Inventor score
Files withALBERT EINSTEIN COLLEGE MEDICINE26DANA FARBER CANCER INST INC8ALBERT EINSTEIN COLLEGE MEDICINE INC5EINSTEIN COLL MED1MEMORIAL SLOAN KETTERING CANCER CENTER1
Top patents by PatentIndex Score
42 records- 0192US9303024B2Pyrazol-3-ones that activate pro-apoptotic BAXDANA FARBER CANCER INST INC·Filed 2012·Granted Apr 5, 2016·15 cites·21 claims
- 0291US10351554B2Pyrazol-3-ones that activate pro-apoptotic BAXDANA FARBER CANCER INST INC·Filed 2018·Granted Jul 16, 2019·7 cites·26 claims
- 0390US10000478B2Pyrazol-3-ones that activate pro-apoptotic BAXDANA FARBER CANCER INST INC·Filed 2016·Granted Jun 19, 2018·6 cites·28 claims
- 0488US10844053B2Pyrazol-3-ones that activate pro-apoptotic BAXDANA FARBER CANCER INST INC·Filed 2019·Granted Nov 24, 2020·4 cites·12 claims
- 0588US10766886B2Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Sep 8, 2020·3 cites·11 claims
- 0687US11358960B2Pyrazol-3-ones that activate pro-apoptotic BAXDANA FARBER CANCER INST INC·Filed 2020·Granted Jun 14, 2022·1 cites·10 claims
- 0785US9890143B2Retinoic acid receptor antagonists as chaperone-mediated authophagy modulators and uses thereofALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2016·Granted Feb 13, 2018·2 cites·25 claims
- 0884US9512092B2Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereofALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2014·Granted Dec 6, 2016·2 cites·20 claims
- 0984US8921323B2Methods and compositions for modulating BCL-2 family polypeptidesWALENSKY LOREN D·Filed 2008·Granted Dec 30, 2014·10 cites·2 claims
- 1082US11382898B2BAX activators and uses thereof in cancer therapyALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Jul 12, 2022·2 cites·13 claims
- 1182US10189827B2Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereofALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2018·Granted Jan 29, 2019·1 cites·7 claims
- 1279US2022298154A1Pyrazol-3-ones that activate pro-apoptotic baxDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1375US2025032462A1Bax activators and uses thereof in cancer therapyALBERT EINSTEIN COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 1471US11174308B2Synthetic antibodies to BAX and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted Nov 16, 2021·0 cites·9 claims
- 1570US11813268B2Mitofusin activators and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Nov 14, 2023·1 cites·16 claims
- 1670US10759851B2Synthetic antibodies to BAX and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Sep 1, 2020·0 cites·9 claims
- 1769US12016845B2BAX activators and uses thereof in cancer therapyALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Granted Jun 25, 2024·0 cites·25 claims
- 1869US11591324B2Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted Feb 28, 2023·0 cites·15 claims
- 1967US2024156872A1Use of Chaperone-Mediated Autophagy Activators For Treating Or Preventing Blood Cancers And Myelodysplastic Syndromes And Enriching Hematopoietic Stem Cell PopulationsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 2066US11760780B2Targeting dimerization of BAX to modulate BAX activityALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Sep 19, 2023·0 cites·9 claims
- 2164US2024350482A1Small molecule bax inhibitors and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 2263US10294294B2Synthetic antibodies to BAX and uses thereofALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2016·Granted May 21, 2019·0 cites·9 claims
- 2362US2024335455A1Mitofusin activators and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 2462US2025000857A1Small molecule bax inhibitors and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 2561US2024043389A1Compounds and methods for inhibition of bax-mediated cell deathALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 2661US2024366540A1Mitofusin inhibitors and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 2761US2011218155A1Chemical modulators of pro-apoptotic bax and bcl-2 polypeptidesDANA FARBER CANCER INST INC·Filed 2009·Application pending·0 cites
- 2858US2025134095A1Compositions for organ and tissue preservationALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 2958US2024189307A1Methods of stabilizing the neuronal proteome against collapse and protecting vascular cellsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 3058US2023372307A1Combination therapy using bax activator agentALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 3157US2024207282A1Method of increasing chaperone mediated autophagy by stabilizing the interaction of retinoic acid receptor-alpha and an inhibitorALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 3256US2023270721A1Inhibition of bax-mediated cell death by eltrombopagALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 3354US12473266B2Benzoxazole and related compounds useful as chaperone-mediated autophagy modulatorsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Nov 18, 2025·0 cites·18 claims
- 3453US11938128B2Small molecule BAX inhibitors and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Mar 26, 2024·0 cites·22 claims
- 3553US2017114100A1Targeting dimerization of bax to modulate bax activityALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2015·Application pending·0 cites
- 3653US2016171150A1Chemical Modulators of Pro-Apoptotic BAX and BCL-2 PolypeptidesDANA FARBER CANCER INST INC·Filed 2014·Application pending·0 cites
- 3752US2022402881A1Small molecule prostagladin transport inhibitorsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 3847US11834424B2Compounds useful as chaperone-mediated autophagy modulatorsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Dec 5, 2023·0 cites·19 claims
- 3947US11098021B2Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Aug 24, 2021·0 cites·25 claims
- 4047US2015335671A1Small-molecule binding site on pro-apoptotic bax regulates inhibition of bax activityEINSTEIN COLL MED·Filed 2014·Application pending·0 cites
- 4146US2023303551A1N-cyclyl-sulfonamides useful for inhibiting rafALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 4241US12440494B2Compounds useful for inhibiting RAF dimersALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted Oct 14, 2025·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Evripidis Gavathiotis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →